Cytological evaluation and investigation of the vaginal flora of long-term users of the levonorgestrel-releasing intrauterine system (LNG-IUS)

Contraception

Volumn 77, Issue 1, 2008, Pages 30-33

  Lessard, Trícia ^a   Simões, José A ^a   Discacciati, Michelle G ^a   Hidalgo, Margarete ^a   Bahamondes, Luis ^a  

^a Department of Obstetrics and Gynecology School of Medicine Universida de Estadual de Campinas   (Brazil)

Author keywords

Candidiasis; Cytopathological abnormalities; LNG IUS; Microbiological abnormalities; Papanicolaou; Vaginal flora

Indexed keywords

LEVONORGESTREL;

ADULT; ARTICLE; CANDIDIASIS; CONTROLLED STUDY; CYTOLOGY; DIAGNOSTIC PROCEDURE; FAMILY PLANNING; FEMALE; FOLLOW UP; HUMAN; INTRAUTERINE CONTRACEPTIVE DEVICE; MAJOR CLINICAL STUDY; UTERINE CERVIX CYTOLOGY; VAGINA FLORA; WOMEN'S HEALTH;

ADOLESCENT; ADULT; BRAZIL; CERVIX UTERI; CONTRACEPTIVE AGENTS, FEMALE; FEMALE; FOLLOW-UP STUDIES; HUMANS; INTRAUTERINE DEVICES, MEDICATED; LEVONORGESTREL; LONGITUDINAL STUDIES; VAGINA; VAGINAL SMEARS; VAGINITIS;

EID: 38149054883     PISSN: 00107824     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.contraception.2007.09.009     Document Type: Article

References (24)

1. World Health Organization. Cervical cancer control in developing countries: memorandum from a WHO meeting. Bull World Health Organ 74 (1996) 345-351
2. Misra J.S., Tandon P., Srivastava A., Das K., Chandrawti C., and Saxena N.C. Cervical cytological studies in women inserted with Norplant-I contraceptive. Diagn Cytopathol 29 (2003) 136-139
3. Sturridge F., and Guillebaud J. Gynecological aspects of the levonorgestrel-releasing intrauterine system. Br J Obstet Gynaecol 104 (1997) 285-289
4. Chick P.H., Frances M., and Paterson P.J. A comprehensive review of female sterilization - tubal occlusion methods. Clin Reprod Fertil 3 (1985) 81-97
5. Luukkainen T., Lähteenmäki P., and Toivonen J. Levonorgestrel-releasing intrauterine device. Ann Med 22 (1990) 85-90
6. Hidalgo M., Bahamondes L., Perrotti M., Diaz J., Dantas-Monteiro C., and Petta C. Bleeding patterns and clinical performance of the levonorgestrel-releasing intrauterine system (Mirena) up to two years. Contraception 65 (2002) 129-132
7. Lockhat F.B., Emembolu J.O., and Konje J.C. The evaluation of the effectiveness of an intrauterine-administered progestogen (levonorgestrel) in the symptomatic treatment of endometriosis and in the staging of the disease. Hum Reprod 19 (2004) 179-184
8. Valente P.T., Schantz H.D., and Trabal J.F. Cytologic changes in cervical smears associated with prolonged use of depot-medroxyprogesterone acetate. Cancer 84 (1998) 328-334
9. Powell L.C., and Seymour R.J. Effects of depo-medroxyprogesterone acetate as a comparative agent. Am J Obstet Gynecol 110 (1971) 36-41
10. World Health Organization. Depot-medroxyprogesterone acetate (DMPA) and cancer: memorandum from a WHO meeting. Bull World Health Organ 64 (1986) 375-382
11. Misra J.S., Engineer A.D., and Tandon P. Cervical cytology associated with levonorgestrel contraception. Acta Cytol 39 (1995) 45-49
12. Avonts D., Sercu M., Heyerick P., Vandermeeren I., Meheus A., and Piot P. Incidence of uncomplicated genital infections in women using oral contraception or an intrauterine device: a prospective study. Sex Transm Dis 17 (1990) 23-29
13. Calzolari E., Masciangelo R., Milite V., and Verteramo R. Bacterial vaginosis and contraceptive methods. Int J Gynaecol Obstet 70 (2000) 341-346
14. Joesoef M.R., Karundeng A., Runtupalit C., Moran J.S., Lewis J.S., and Ryan C.A. High rate of bacterial vaginosis among women with intrauterine devices in Manado, Indonesia. Contraception 64 (2001) 169-172
15. Ferraz do Lago R., Simões J.A., Bahamondes L., Camargo R.P., Perrotti M., and Monteiro I. Follow-up of users of intrauterine device with and without bacterial vaginosis and other cervicovaginal infections. Contraception 68 (2003) 105-109
16. Toivonen J., Luukkainen T., and Allonen H. Protective effect of intrauterine release of levonorgestrel on pelvic infection: three years' comparative experience of levonorgestrel- and copper-releasing intrauterine devices. Obstet Gynecol 77 (1991) 261-264
17. Andersson K., Odlind V., and Rybo G. Levonorgestrel-releasing and copper-releasing (Nova-T) IUDs during five years of use: a randomized comparative trial. Contraception 49 (1994) 56-72
18. Solomon D., Davey D., Kurman R., et al. The 2001 Bethesda system terminology for reporting results of cervical cytology. JAMA 287 (2002) 2114-2119
19. Discacciati M.G., Simoes J.A., Amaral R.G., et al. Presence of 20% or more clue cells: an accurate criterion for the diagnosis of bacterial vaginosis in Papanicolaou cervical smears. Diagn Cytophatol 34 (2006) 272-276
20. Darwish A., Labeeb S., Galal M., Rashad H., and Hassan S. Cervical changes associated with progestagen-only contraceptives: a team approach. Contraception 69 (2004) 121-127
21. Luukkainen T., Pakarinen P., and Toivonen J. Progestin-releasing intrauterine systems. Semin Reprod Med 19 (2001) 355-363
22. Sivin I., Stern J., Coutinho E., et al. Prolonged intrauterine contraception: a seven-year randomized study of the levonorgestrel 20 μg/day (LNg20) and the cooper T380 Ag IUDs. Contraception 44 (1991) 473-480
23. Diaz J., Faúndes A., Diaz M., and Marchi N. Evaluation of the clinical performance of a levonorgestrel-releasing IUD, up to seven years of use, in Campinas, Brazil. Contraception 47 (1993) 169-175
24. Miller L., Patton D.L., Meier A., Thwin S.S., Hooton T.M., and Eschenbach D.A. Depo-medroxyprogesterone-induced hypoestrogenism and changes in vaginal flora and epithelium. Obstet Gynecol 96 (2000) 431-439